gallium-ga-68-dotatate and Fibrous-Dysplasia-of-Bone

gallium-ga-68-dotatate has been researched along with Fibrous-Dysplasia-of-Bone* in 1 studies

Other Studies

1 other study(ies) available for gallium-ga-68-dotatate and Fibrous-Dysplasia-of-Bone

ArticleYear
Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    Fibrous dysplasia of the bone is a developmental benign skeletal disorder characterized by replacement of normal bone and normal bone marrow with abnormal fibro-osseous tissue. We report on a case of a biopsy-proven fibrous dysplasia lesion in the left temporal bone, with intensely increased activity (SUVmax, 56.7) on Ga-DOTATATE PET/CT. The presented data indicate cell surface overexpression of somatostatin receptors by fibrous dysplastic cells and highlight the need of cautious management of Ga-DOTATATE-avid bone lesions, which could mimic malignancy especially in patients with history of neuroendocrine tumors.

    Topics: Aged; Diagnosis, Differential; Fibrous Dysplasia of Bone; Humans; Male; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017